European Union/U.K. R&D Like most other regions of the world, the European Union (EU) and the U.K. have been caught in the COVID-19 pandemic lockdown and economic consequences. In April, the U.K., the world’s sixth largest economy, saw its output drop 20% from March and 25% from April 2019. The U.K.’s Office for National Statistics…
Researchers develop a fast, accurate, low-cost COVID-19 test
by PLOS A new low-cost diagnostic test for COVID-19 quickly delivers accurate results without the need for sophisticated equipment, according to a study published August 27 2020 in the open-access journal PLOS Pathogens by Teng Xu of the Vision Medicals Center for Infectious Diseases, Tieying Hou of the Guangdong Academy of Medical Sciences, Bing Gu…
Syringe technology could enable injection of concentrated biologic drugs
By Michaela Jarvis | MIT News correspondent MIT researchers have developed a simple, low-cost technology to administer powerful drug formulations that are too viscous to be injected using conventional medical syringes. The technology, which is described in a paper published today in the journal Advanced Healthcare Materials, makes it possible to inject high-concentration drugs and…
Illinois-based Novation Industries reaches unprecedented production volumes for PPE due to COVID-19
Novation Industries, an Illinois-based injection molding and vertically integrated product production company, received increased production orders for personal protection equipment (PPE) and rapidly replied to demand. Increased order volume, which started in April and will continue at least through September, includes molding and complete product assembly of face protection products. Novation produces the PPE for an…
Global R&D Funding Forecast: Special mid-year update, Part 1
By Tim Studt This special editorial section is an update to R&D World’s 2020 Global R&D Funding Forecast (GFF), which has been published annually since January 1959 (the first issue of R&D World’s predecessor, Industrial Research). The original 2020 GFF was created and published in the February 2020 issue of R&D World (and online at www.rdworldonline.com)…
PerkinElmer launches modular and scalable explorer workstations for high-throughput COVID-19 detection
PerkinElmer (NYSE:PKI) today announced the launch of a series of explorer workstations for SARS-CoV-2 testing capable of preparing and running up to 10,000 COVID-19 tests per day. These modular and scalable workstations enable laboratories to ramp up SARS-CoV-2 testing capacity quickly to generate results. Currently many laboratories are unable to deliver COVID-19 testing results in…
SLAC scientists invent low-cost emergency ventilator and share the design for free
By Manuel Gnida Researchers at the Department of Energy’s SLAC National Accelerator Laboratory have invented an emergency ventilator that could help save the lives of patients suffering from COVID-19, the disease caused by novel coronavirus SARS-CoV-2. Using standard parts that cost less than $400, the ventilator could be an affordable option when more sophisticated technology…
Fast-tracking diagnostic testing for COVID-19 and other viruses
When plasma equipment manufacturer PVA TePla America was asked by a manufacturer of real-time PCR diagnostic tests, to treat hundreds of thousands of plastic cartridges used to test for COVID-19, they immediately jumped at the task. Plasma is a state of matter, like a solid, liquid or gas. When enough energy is added to a…
Biological Sciences professor hopes research can reveal mechanisms that influence viral infection
Auburn University Assistant Professor of Biological Sciences Joanna Sztuba-Solinska recently received a big boost in her quest to discover what makes viruses target specific enzymes within cells. The accomplished researcher and her team received a $451,661 grant from the National Institutes of Health or NIH, that will propel her team’s research tasked with discovering the…
New intranasal vaccine platform provides potential for more effective vaccines with fewer side effects
By Alison Caldwell PhD The ongoing COVID-19 pandemic is shining a bright spotlight on vaccine development. As numerous vaccines race through clinical trials, physicians and researchers continue to work on developing new vaccine technologies to generate the most effective vaccines with the fewest side effects. A new proof-of-concept study by researchers at the University of…
Helping protect medical professionals
By Manette Fisher A media comprised of a sandwich of materials, tested by Sandia National Laboratories, is being manufactured into N95-like respirators that could be used in local medical facilities. The project originated from the urgent need for personal protective equipment when the COVID-19 outbreak began. “I can almost assure you that no one else…
Transportation – Gauging pandemic impact
Oak Ridge National Laboratory researchers have developed a machine learning model that could help predict the impact pandemics such as COVID-19 have on fuel demand in the United States. Called the Pandemic Oil Demand Analysis, or PODA, this model compared mobility patterns before and during the COVID-19 pandemic, analyzing historical weekly motor travel trends and…
Engineers developing no-touch, mail-in, fast-scan test for COVID-19, other outbreaks
by Iowa State University There would be no tents set up in parking lots. No long lines of cars. No medical staff in full protective gear. No waiting for results. Instead, you’d take your own COVID-19 diagnostic test at home with a $1 (or so) kit. You’d take your own nasal and cough samples. You’d…
Copper alloy kills coronavirus within 10 minutes
A team of scientists at the University of Southampton have established significant results in the elimination of Covid-19 within minutes, on a copper-based alloy, demonstrating its ability to reduce coronavirus transmission rates, via commonly touched surfaces, manufactured with this metal. Working with Sylatech, an engineering business in North Yorkshire, U.K., Professor Bill Keevil, Dr. SandraWilks…
Ready to join the fight against COVID-19
On July 29, 2020 the U.S. Department of Energy’s (DOE) Brookhaven National Laboratory opened a new cryo-electron microscopy center, the Laboratory for BioMolecular Structure (LBMS), with an initial focus on COVID-19-related research. This state-of-the-art research center for life sciences imaging offers researchers access to advanced cryo-electron microscopes (cryo-EM) — funded by NY State — for…
Computational gene study suggests new pathway for COVID-19 inflammatory response
By Sara S Shoemaker Analyses of lung fluid cells from COVID-19 patients conducted on the nation’s fastest supercomputer point to gene expression patterns that may explain the runaway symptoms produced by the body’s response to SARS-CoV-2. A team led by Dan Jacobson of the Department of Energy’s Oak Ridge National Laboratory used the Summit supercomputer…
PerkinElmer launches online, open access COVID-19 Data Dashboards to accelerate antiviral therapeutics research
PerkinElmer, a global leader committed to innovating for a healthier world, today announced that it has launched two online, free-access Perkin Elmer COVID-19 Data Dashboards to help the global scientific community accelerate the discovery of COVID-19 antivirals and vaccines. These dashboards are powered by PerkinElmer’s data analytics and data visualization solutions which help researchers more…
Scientists race to develop an effective COVID-19 vaccine
With the global pandemic still in full swing, scientists are working to develop a vaccine in record time. While everyone wants an effective vaccine, they don’t all agree on how to get there and what “effective” really means. Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society, spoke with researchers, doctors and…
Thermo Fisher Scientific expands their COVID-19 support to development and production of therapeutics and vaccines
Thermo Fisher Scientific (NYSE: TMO) continues to expand global capacity and capabilities across its leading pharma services network to support customers in government, industry and academia as they accelerate development and production of COVID-19 vaccines, therapies and other treatments. The company is now supporting more than 200 of these projects globally. “Well before the pandemic,…
Clues to COVID-19 treatments could be hiding in existing data – these scientists want to find them
By Aliyah Kovner If you want to research historical events for a college essay, learn about tropical fish, or even translate text into a different language, you can type keywords into an internet search engine and get almost instant results drawn from diverse, international sources on that subject. Unfortunately, it’s not so easy for the…
Arctoris contributes its capabilities and expertise to the fight against COVID-19
Scientists in academic centers and companies around the world desperately search for novel therapeutics and vaccines to treat and prevent COVID-19. However, with lockdowns and limited access to laboratories, researchers are being forced to work from home, putting research continuity at risk. To help scientists continue their life-saving R&D, and ensure research continuity, Arctoris established…
Finding COVID-19 needles in a coronavirus haystack
By Luke Frank COVID-19 researchers the world over face a daunting task of sifting through tens of thousands of existing coronavirus studies, looking for commonalities or data that might help in their urgent biomedical investigations. To accelerate the filtering of relevant information, Sandia National Laboratories has assembled a combination of data mining, machine-learning algorithms and…
Colorado-based New Iridium accelerating global production of potential COVID-19 treatment using light-driven chemistry
New Iridium, a company developing commercialized photocatalysis technologies to accelerate drug development and manufacturing, has been awarded a National Science Foundation (NSF) Small Business Technology Transfer (STTR) grant for $256,000 to conduct research and development work on facilitating timely availability of Remdesivir, a potential life-saving drug in the global fight against COVID-19. This grant funds the development of an optimized…
Engineers use “DNA origami” to identify vaccine design rules
By Anne Trafton, MIT News Office By folding DNA into a virus-like structure, MIT researchers have designed HIV-like particles that provoke a strong immune response from human immune cells grown in a lab dish. Such particles might eventually be used as an HIV vaccine. The DNA particles, which closely mimic the size and shape of…
Science collaborations find a way during COVID-19 pandemic
By Glenn Roberts Jr. Even an underground experiment 4,600 feet below a mountain in Central Italy, and a telescope instrument more than a mile high atop an Arizona mountaintop could not escape the impacts of the COVID-19 pandemic. As the virus spread around the world, many laboratories and experiment sites entered a period of partial…